GLP-1 analogues delay gastric emptying ( When initiating GLP-1based therapy, clinicians should adhere to the principle of do no harm , particularly during the early phases of treatment when gastrointestinal adverse effects are most likely to emerge ( Potentially the easiest way to prevent nausea and vomiting is by starting at a low dose ( In most cases of Grade 1 or 2 nausea, maintaining the current dose for one to two additional dosing intervals is sufficient to allow symptom resolution
The discomfort typically lasts until the viral infection clears
Lyophilized cagrilintide is stored at -20C for long-term storage and 2-8C for short-term use within 30 days
bones, joints and cartilage
(9 October 2020) NHMRC COVID-19: Guidance on Clinical Trials for Institutions, HRECs, Researchers and Sponsors
The decision framework should prioritize individual health status, specific therapeutic goals, and risk tolerance